Nidan Laboratories and Healthcare Limited (NSE:NIDAN)
India · Delayed Price · Currency is INR 16.60
+0.10 (0.61%)
At close: Mar 6, 2026
NSE:NIDAN Revenue
Nidan Laboratories and Healthcare had revenue of 131.21M INR in the half year ending September 30, 2025, with 10.97% growth. This brings the company's revenue in the last twelve months to 271.16M, up 18.48% year-over-year. In the fiscal year ending March 31, 2025, Nidan Laboratories and Healthcare had annual revenue of 245.28M with 1.45% growth.
Revenue (ttm)
271.16M
Revenue Growth
+18.48%
P/S Ratio
0.85
Revenue / Employee
1.66M
Employees
163
Market Cap
230.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 245.28M | 3.50M | 1.45% |
| Mar 31, 2024 | 241.77M | -885.00K | -0.36% |
| Mar 31, 2023 | 242.66M | -53.94M | -18.19% |
| Mar 31, 2022 | 296.60M | 88.68M | 42.65% |
| Mar 31, 2021 | 207.92M | -13.91M | -6.27% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indraprastha Medical Corporation | 14.51B |
| Shalby | 11.19B |
| Artemis Medicare Services | 10.42B |
| GPT Healthcare | 4.48B |
| Max India | 1.84B |
| Vaidya Sane Ayurved Laboratories | 979.90M |
| Unihealth Hospitals | 789.82M |
| Lotus Eye Hospital and Institute | 516.17M |